Psychiatry · Northridge, CA
NPI
1043394505
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
17075 Devonshire St, Ste 204
Northridge, CA, 91325
Phone (818) 368-8929
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
2,085 services
Medicare patients, 2024
750
Average age 73
Drug cost, 2024
$2.1M
10,065 prescriptions
Company payments, 2025
$33K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fawzy S Basta Sr. was code 99232 (hospital e&m - subsequent), 493 times for 117 patients. In total Fawzy S Basta Sr. billed 2,085 services in 18 codes, and Medicare paid $136K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-01-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 493 | 117 | $58.96 | $29K |
| 99307 SNF E&M | Facility | 391 | 229 | $29.85 | $12K |
| 99305 SNF E&M | Facility | 327 | 323 | $99.76 | $33K |
| 99213 Office E&M - Established | Office | 307 | 65 | $65.49 | $20K |
| 99222 Hospital E&M - Initial | Facility | 246 | 161 | $97.72 | $24K |
| 99231 Hospital E&M - Subsequent | Facility | 124 | 46 | $36.93 | $4,580 |
| 99238 Hospital Discharge Management | Facility | 119 | 63 | $61.50 | $7,318 |
| 90833 Psychotherapy - Nongroup | Office | 23 | 13 | $54.66 | $1,257 |
| 99306 SNF E&M | Facility | 15 | 15 | $138.30 | $2,075 |
| 99347 Home E&M - New and Established | Office | 14 | 12 | $34.24 | $479 |
By year: 2022 $176K for 2,690 services; 2023 $163K for 2,386 services; 2024 $136K for 2,085 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fawzy S Basta Sr. prescribed most often to Medicare patients was Clonazepam, with 949 prescriptions and refills. In total Fawzy S Basta Sr. wrote 10,065 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 949 | 972 | 150 | $9,288 |
| Quetiapine Fumarate Generic | 904 | 993 | 127 | $13K |
| Lorazepam Generic | 479 | 495 | 98 | $3,585 |
| Olanzapine Generic | 453 | 523 | 66 | $14K |
| Benztropine Mesylate Generic | 449 | 479 | 62 | $7,154 |
| Mirtazapine Generic | 442 | 485 | 72 | $9,598 |
| Trazodone Hcl Generic | 382 | 448 | 71 | $3,920 |
| Clozapine Generic | 347 | 349 | 26 | $39K |
| Haloperidol Generic | 343 | 382 | 48 | $16K |
| Divalproex Sodium Generic | 342 | 367 | 52 | $11K |
| Risperidone Generic | 327 | 342 | 53 | $5,200 |
| Buspirone Hcl Generic | 316 | 339 | 57 | $3,302 |
| Alprazolam Generic | 263 | 276 | 34 | $1,299 |
| Zolpidem Tartrate Generic | 261 | 273 | 39 | $1,503 |
| Escitalopram Oxalate Generic | 228 | 301 | 43 | $1,791 |
Brand drugs: 514 claims; generic drugs: 9,551 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fawzy S Basta Sr. $33K ($33K in general payments such as food, travel and fees) from 19 companies. The largest payer was Neurocrine BioSciences, Inc. with $17K.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 35 | $17K |
| ACADIA Pharmaceuticals Inc ACAD | 15 | $12K |
| Abbvie Inc. ABBV | 24 | $667 |
| Teva Pharmaceuticals USA, Inc. TEVA | 30 | $549 |
| E.R. Squibb & Sons, L.L.C. BMY | 23 | $522 |
| Vanda Pharmaceuticals Inc. VNDA | 10 | $318 |
| Alpha Cognition USA, Inc. ACOG | 7 | $238 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 11 | $227 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 9 | $168 |
| Bausch Health US, LLC BHC | 8 | $149 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.